Literature DB >> 3017356

Prostaglandins and cannabis--XVI. Antagonism of delta 1-tetrahydrocannabinol action by its metabolites.

S Burstein, S A Hunter, V Latham, L Renzulli.   

Abstract

Prior exposure of cells in vitro to delta 1-tetrahydrocannabinol-7-oic acid (delta 1-THC-7-oic acid) reduced the degree of stimulation of prostaglandin synthesis incurred by subsequent treatment with delta 1-THC. The site of action of this inhibitory effect seemed to be on cyclooxygenase and not at the earlier step involving the phospholipase-mediated release of arachidonic acid. delta 1-THC-7-oic acid is a major metabolite of delta 1-THC and has no psychoactivity in humans. Our findings raise the possibility, however, that it may influence the in vivo activities of delta 1-THC by antagonizing its stimulatory action on cellular prostaglandin synthesis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3017356     DOI: 10.1016/0006-2952(86)90053-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

Review 1.  Ajulemic acid (IP-751): synthesis, proof of principle, toxicity studies, and clinical trials.

Authors:  Summer Burstein
Journal:  AAPS J       Date:  2005-06-29       Impact factor: 4.009

2.  A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice.

Authors:  S Burstein; S A Hunter; V Latham; L Renzulli
Journal:  Experientia       Date:  1987-04-15

3.  Pharmacological evaluation of the natural constituent of Cannabis sativa, cannabichromene and its modulation by Δ(9)-tetrahydrocannabinol.

Authors:  Gerald T DeLong; Carl E Wolf; Alphonse Poklis; Aron H Lichtman
Journal:  Drug Alcohol Depend       Date:  2010-11-01       Impact factor: 4.492

4.  Further studies on the antinociceptive effects of delta 6-THC-7-oic acid.

Authors:  S A Doyle; S H Burstein; W L Dewey; S P Welch
Journal:  Agents Actions       Date:  1990-08

Review 5.  The cannabinoid acids, analogs and endogenous counterparts.

Authors:  Sumner H Burstein
Journal:  Bioorg Med Chem       Date:  2014-04-01       Impact factor: 3.641

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.